UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 110

Sortiert nach

Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy

JAMA dermatology (Chicago, Ill.), 2024-05, Vol.160 (5), p.577

2024

Volltextzugriff (PDF)

The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study

Journal of the American Academy of Dermatology, 2017-01, Vol.76 (1), p.54-59

2017

Volltextzugriff (PDF)

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Journal of the American Academy of Dermatology, 2012-11, Vol.67 (5), p.1025-1039

2012

Volltextzugriff (PDF)

Trial of Spesolimab for Generalized Pustular Psoriasis

The New England journal of medicine, 2021-12, Vol.385 (26), p.2431-2440

2021

Volltextzugriff (PDF)

Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset

Journal of the American Academy of Dermatology, 2016-09, Vol.75 (3), p.632-634

2016

Volltextzugriff (PDF)

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

Supportive care in cancer, 2011-08, Vol.19 (8), p.1079-1095

2011

Volltextzugriff (PDF)

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines

The oncologist (Dayton, Ohio), 2021-02, Vol.26 (2), p.e316-e326

2021

Volltextzugriff (PDF)

SnapshotDx Quiz: September 2019

Journal of investigative dermatology, 2019-09, Vol.139 (9), p.e99-e102

2019

Volltextzugriff (PDF)

Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit

JAMA dermatology (Chicago, Ill.), 2022-12, Vol.158 (12), p.1378

2022

Volltextzugriff (PDF)

SnapshotDx Quiz: May 2019

Journal of investigative dermatology, 2019-05, Vol.139 (5), p.e47-e51

2019

Volltextzugriff (PDF)

SnapshotDx Quiz: January 2019

Journal of investigative dermatology, 2019-01, Vol.139 (1), p.e1-e4

2019

Volltextzugriff (PDF)

EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections

Supportive care in cancer, 2016-09, Vol.24 (9), p.3943-3950

2016

Volltextzugriff (PDF)

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

The Lancet (British edition), 2023-10, Vol.402 (10412), p.1541-1551

2023

Volltextzugriff (PDF)

Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study

Journal of the American Academy of Dermatology, 2023-07, Vol.89 (1), p.36-44

2023

Volltextzugriff (PDF)

Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey

Journal of the American Academy of Dermatology, 2021-08, Vol.85 (2), p.396-403

2021

Volltextzugriff (PDF)

SnapshotDx Quiz: May 2020

Journal of investigative dermatology, 2020-05, Vol.140 (5), p.e49-e54

2020

Volltextzugriff (PDF)

SnapshotDx Quiz: January 2020

Journal of investigative dermatology, 2020-01, Vol.140 (1), p.e1-e6

2020

Volltextzugriff (PDF)

Risk of keratinocyte carcinomas following extracorporeal photopheresis among lung transplant recipients: A retrospective cohort study

Journal of the American Academy of Dermatology, 2024-02, Vol.90 (2), p.388-390

2024

Volltextzugriff (PDF)

Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus

Journal of investigative dermatology, 2019-01, Vol.139 (1), p.62-70

2019

Volltextzugriff (PDF)

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Frontiers in oncology, 2020-07, Vol.10, p.1045-1045

2020

Volltextzugriff (PDF)

Measuring improvement in psoriasis and dermatitis: The development of pruritus clinical quality measures

Journal of the American Academy of Dermatology, 2023-01, Vol.88 (1), p.233-234

2023

Volltextzugriff (PDF)

Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists

Journal of the American Academy of Dermatology, 2020-10, Vol.83 (4), p.1150-1159

2020

Volltextzugriff (PDF)

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

Frontiers in oncology, 2023-01, Vol.12, p.975473-975473

2023

Volltextzugriff (PDF)

SnapshotDx Quiz: September 2018

Journal of investigative dermatology, 2018-09, Vol.138 (9), p.e55-e55

2018

Volltextzugriff (PDF)

1 – 25 von 110

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(90)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(110)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(73)
Science & Technology
(73)
Dermatology
(57)
Humans
(56)
Female
(28)
Male
(26)
Middle Aged
(24)
Adult
(16)
Oncology
(16)
Aged
(10)
Biological And Medical Sciences
(10)
Medical Sciences
(10)
Retrospective Studies
(9)
Treatment Outcome
(9)
Antineoplastic Agents - Adverse Effects
(8)
Medicine
(8)
Medicine & Public Health
(7)
Psoriasis
(7)
Receptor, Epidermal Growth Factor - Antagonists & Inhibitors
(7)
Severity Of Illness Index
(7)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Radiation Recall Dermatitis With Bruton Tyrosine Kinase Inhibitor Therapy

The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study

Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0

Trial of Spesolimab for Generalized Pustular Psoriasis

First-in-human phase 1 clinical study of the IL-15 superagonist complex ALT-803 to treat relapse after transplantation

Hidradenitis suppurativa (HS) and Down syndrome (DS): Increased prevalence and a younger age of hidradenitis symptom onset

Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities

Dermatologic Adverse Events Associated with Selective Fibroblast Growth Factor Receptor Inhibitors: Overview, Prevention, and Management Guidelines

SnapshotDx Quiz: September 2019

Factors Associated With Dermatologic Follow-up vs Emergency Department Return in Patients With Hidradenitis Suppurativa After an Initial Emergency Department Visit

SnapshotDx Quiz: May 2019

SnapshotDx Quiz: January 2019

EGFR inhibitor-induced skin reactions: differentiating acneiform rash from superimposed bacterial infections

Efficacy and safety of subcutaneous spesolimab for the prevention of generalised pustular psoriasis flares (Effisayil 2): an international, multicentre, randomised, placebo-controlled trial

Rapid and sustained improvements in Generalized Pustular Psoriasis Physician Global Assessment scores with spesolimab for treatment of generalized pustular psoriasis flares in the randomized, placebo-controlled Effisayil 1 study

Psoriasis and mortality in the United States: Data from the National Health and Nutrition Examination Survey

SnapshotDx Quiz: May 2020

SnapshotDx Quiz: January 2020

Risk of keratinocyte carcinomas following extracorporeal photopheresis among lung transplant recipients: A retrospective cohort study

Chronic Inflammation Promotes Skin Carcinogenesis in Cancer-Prone Discoid Lupus Erythematosus

Prevention and Management of Dermatologic Adverse Events Associated With Tumor Treating Fields in Patients With Glioblastoma

Measuring improvement in psoriasis and dermatitis: The development of pruritus clinical quality measures

Navigating immunosuppression in a pandemic: A guide for the dermatologist from the COVID Task Force of the Medical Dermatology Society and Society of Dermatology Hospitalists

Expert guidance on prophylaxis and treatment of dermatologic adverse events with Tumor Treating Fields (TTFields) therapy in the thoracic region

SnapshotDx Quiz: September 2018

Suchergebnisse filtern